{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-061364","form_type":"8-K","ticker":"PLUR","cik":"0001158780","company_name":"Pluri Inc.","filed_at":"2025-07-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.458667+00:00","generated_at":"2026-05-18T09:25:03.042556+00:00","sec_items":["3.01","5.02","5.07"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Pluri loses director Birger, triggering Nasdaq audit committee non-compliance with cure period","bullets":["Doron Birger not re-elected at June 30 annual meeting; received 1,270,717 for, 2,720,350 against.","Audit Committee now has only 2 independent directors, violating Nasdaq Rule 5605(c)(2)(A).","Nasdaq granted cure period until earlier of next annual meeting or June 30, 2026.","Company intends to appoint an additional independent director to regain compliance.","Shareholders approved 2016 equity plan, advisory vote on exec comp every 2 years, and warrant exercise for Weinstein entity."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-061364","json":"https://secwatch.observer/filing/0001213900-25-061364.json","markdown":"https://secwatch.observer/filing/0001213900-25-061364.md","text":"https://secwatch.observer/filing/0001213900-25-061364.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1158780/000121390025061364/0001213900-25-061364-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1158780/000121390025061364/ea0248143-8k_pluri.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:25:03.042556+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}